Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Madrigal Pharmaceuticals Revenue 2010-2024 | MDGL

Madrigal Pharmaceuticals revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  
Madrigal Pharmaceuticals Annual Revenue
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $0
2011 $8
2010 $15
2009 $144
Madrigal Pharmaceuticals Quarterly Revenue
(Millions of US $)
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31 $0
2011-12-31 $3
2011-09-30 $2
2011-06-30 $1
2011-03-31 $1
2010-12-31 $4
2010-09-30 $3
2010-06-30 $3
2010-03-31 $4
2009-12-31 $5
2009-09-30 $130
2009-06-30 $5
2009-03-31 $5
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.434B $0.000B
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.252B 30.60
Chugai Pharmaceutical (CHGCY) Japan $52.146B 23.31
Takeda Pharmaceutical (TAK) Japan $41.333B 6.70
Merck (MKGAF) Germany $21.344B 20.14
Astellas Pharma (ALPMY) Japan $17.961B 28.36
Sandoz Group AG (SDZNY) Switzerland $14.913B 0.00
Shionogi (SGIOY) Japan $14.127B 12.67
Neurocrine Biosciences (NBIX) United States $13.991B 38.30
United Therapeutics (UTHR) United States $11.581B 12.35
Catalent (CTLT) United States $10.171B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.637B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.978B 7.67
Revolution Medicines (RVMD) United States $6.532B 0.00
Ionis Pharmaceuticals (IONS) United States $5.862B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Alpine Immune Sciences (ALPN) United States $4.242B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.007B 0.00
Summit Therapeutics (SMMT) United States $3.482B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.125B 0.00
Corcept Therapeutics (CORT) United States $2.644B 23.96
Indivior (INDV) United States $2.451B 11.62
PTC Therapeutics (PTCT) United States $2.388B 0.00
Dyne Therapeutics (DYN) United States $2.245B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.023B 11.56
Recursion Pharmaceuticals (RXRX) United States $2.016B 0.00
Ardelyx (ARDX) United States $1.973B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.945B 0.00
Evotec AG (EVO) Germany $1.839B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.820B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.737B 16.92
Taro Pharmaceutical Industries (TARO) Israel $1.589B 27.82
Soleno Therapeutics (SLNO) United States $1.546B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.472B 0.00
Xencor (XNCR) United States $1.459B 0.00
Pacira BioSciences (PCRX) United States $1.380B 13.12
4D Molecular Therapeutics (FDMT) United States $1.347B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.271B 11.94
Collegium Pharmaceutical (COLL) United States $1.245B 7.66
Enliven Therapeutics (ELVN) United States $1.151B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.053B 0.00
Cronos Group (CRON) Canada $0.986B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.955B 0.00
Cassava Sciences (SAVA) United States $0.933B 0.00
Ocular Therapeutix (OCUL) United States $0.891B 0.00
ARS Pharmaceuticals (SPRY) United States $0.878B 0.00
Relay Therapeutics (RLAY) United States $0.864B 0.00
USANA Health Sciences (USNA) United States $0.858B 14.02
Sage Therapeutics (SAGE) United States $0.746B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.735B 0.00
Savara (SVRA) United States $0.690B 0.00
Silence Therapeutics (SLN) United Kingdom $0.676B 0.00
Lyell Immunopharma (LYEL) United States $0.637B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.613B 0.00
Exscientia (EXAI) United Kingdom $0.566B 0.00
ProKidney (PROK) United States $0.555B 0.00
Siga Technologies (SIGA) United States $0.533B 6.82
OmniAb (OABI) United States $0.532B 0.00
Verve Therapeutics (VERV) United States $0.510B 0.00
KalVista Pharmaceuticals (KALV) United States $0.509B 0.00
Altimmune (ALT) United States $0.508B 0.00
Larimar Therapeutics (LRMR) United States $0.505B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.461B 0.00
Heron Therapeutics (HRTX) United States $0.453B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.453B 0.00
Lexeo Therapeutics (LXEO) United States $0.452B 0.00
Korro Bio (KRRO) United States $0.420B 0.00
Bioventus (BVS) United States $0.399B 15.27
Tourmaline Bio (TRML) United States $0.399B 0.00
Esperion Therapeutics (ESPR) United States $0.387B 0.00
Harrow (HROW) United States $0.365B 0.00
Black Diamond Therapeutics (BDTX) United States $0.365B 0.00
Nanobiotix S.A (NBTX) France $0.325B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.323B 0.00
Organogenesis (ORGO) United States $0.305B 57.75
Nektar Therapeutics (NKTR) United States $0.301B 0.00
ESSA Pharma (EPIX) Canada $0.298B 0.00
Nature's Sunshine Products (NATR) United States $0.295B 18.76
Akebia Therapeutics (AKBA) United States $0.293B 0.00
Fractyl Health (GUTS) United States $0.290B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Xeris Biopharma Holdings (XERS) United States $0.274B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.270B 0.00
Eliem Therapeutics (ELYM) United States $0.258B 0.00
Metagenomi (MGX) United States $0.255B 0.00
Foghorn Therapeutics (FHTX) United States $0.255B 0.00
Adherex Technologies (FENC) United States $0.253B 0.00
Pyxis Oncology (PYXS) United States $0.251B 0.00
Aldeyra Therapeutics (ALDX) United States $0.242B 0.00
Avita Medical (RCEL) United States $0.231B 0.00
Zevra Therapeutics (ZVRA) United States $0.224B 0.00
Conduit Pharmaceuticals (CDT) United States $0.218B 0.00
Galectin Therapeutics (GALT) United States $0.201B 0.00
Century Therapeutics (IPSC) United States $0.199B 0.00
Acrivon Therapeutics (ACRV) United States $0.186B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Telomir Pharmaceuticals (TELO) United States $0.176B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.174B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Achieve Life Sciences (ACHV) Canada $0.161B 0.00
Incannex Healthcare (IXHL) Australia $0.156B 0.00
CytoDyn (CYDY) United States $0.153B 0.00
Prelude Therapeutics (PRLD) United States $0.151B 0.00
Regulus Therapeutics (RGLS) United States $0.149B 0.00
Elite Pharmaceuticals (ELTP) United States $0.141B 13.20
Cardiol Therapeutics (CRDL) Canada $0.137B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.131B 2.76
VAXART, INC (VXRT) United States $0.129B 0.00
Inotiv (NOTV) United States $0.123B 0.00
Karyopharm Therapeutics (KPTI) United States $0.119B 0.00
OptiNose (OPTN) United States $0.118B 0.00
Relmada Therapeutics (RLMD) United States $0.116B 0.00
FibroGen (FGEN) United States $0.112B 0.00
PMV Pharmaceuticals (PMVP) United States $0.111B 0.00
Citius Pharmaceuticals (CTXR) United States $0.106B 0.00
Assertio Holdings (ASRT) United States $0.100B 4.59
ProPhase Labs (PRPH) United States $0.097B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
AlloVir (ALVR) United States $0.090B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.079B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Tempest Therapeutics (TPST) United States $0.077B 0.00
Jaguar Animal Health (JAGX) United States $0.074B 0.00
Journey Medical (DERM) United States $0.071B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.98
Champions Oncology (CSBR) United States $0.066B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Carisma Therapeutics (CARM) United States $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.061B 0.00
BioLineRx (BLRX) Israel $0.053B 0.00
Gain Therapeutics (GANX) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
JanOne (JAN) United States $0.039B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Protara Therapeutics (TARA) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
DURECT (DRRX) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Nutriband (NTRB) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
Lyra Therapeutics (LYRA) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 1.06
PolyPid (PYPD) Israel $0.021B 0.00
BioVie (BIVI) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
CERo Therapeutics Holdings (CERO) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Aptorum Group (APM) United Kingdom $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Clever Leaves Holdings (CLVR) Canada $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Acutus Medical (AFIB) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.23
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.40